On July 20, BeOne Medicines (06160.HK) rose 3.39% in regular trading, trading at HK$192.7/share, with turnover of HK$197 million.
Within the Biotechnology sector where BeOne Medicines belongs, individual stocks broadly strengthened. Among sector peers, Remegen up 6.23%, SKB Bio up 5.37%, Innovent Bio up 3.99%, Akeso up 3.4%, 3SBio up 3.1%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)